There are some potential downsides though, including misuse by those who do not need to lose weight, some gastric side-effects and in limited cases, potentially pancreatitis and gall bladder disorders ...

Falls can often lead to reduced mobility or long-term disability in adults 65 and older, but there are strategies beyond exercise that can help these patients stay independent longer.

Lizzo has revealed working out, playing pickleball and eating an animal protein-rich diet are the factors of her weight loss ...

It’s something that also helps with weight loss and can help with glucose levels, blood sugar levels,” said Dr. Rao. But with pros, there are cons. “For some people, that more gradual weight loss or ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...

The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and glucose control. Unlike conventional GLP-1 receptor agonists, it ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.